KZN join TAC in MTCT court case against Government
In a dramatic turnaround, the KwaZulu-Natal provincial government has withdrawn from government’s appeal today (1 March) against the court ruling compelling it to provide Nevirapine to pregnant HIV positive mothers — and has instead joined forces with government’s court opponent, the Treatment Action Campaign (TAC).
TAC, now supported by KwaZulu-Natal, has applied for the court order granted in its favour on 14 December be enforced — even if government wins the right to appeal against it.
This court order, handed down by Judge Chris Botha on 14 December, compels government to allow health workers to provide all pregnant women known to be HIV positive with the Nevirapine and to develop a credible plan for the roll-out of the drug to all pregnant HIV positive women.
Both applications are due to be heard before Judge Botha in the Pretoria High Court today. (1 March)
In an affidavit due to be made public today, Premier Lionel Mtshali said his province did not support government’s application as KwaZulu-Natal wanted all pregnant women with HIV to have “universal access” to Nevirapine.
Mtshali said his province faced a “calamitous” HIV/AIDS pandemic with an estimated infection rate of 35% and regarded the “urgent and immediate administration of Nevirapine (as) a moral imperative of government”.
His stance comes in the wake of an increasing cooling in relations between the ANC and it’s partner in government, the Inkatha Freedom Party, over HIV/AIDS.
Mtshali acknowledged that the infrastructure was not in place in all provincial health facilities to offer all pregnant women voluntary HIV counselling and testing before giving them the chance to take Nevirapine, the anti-retroviral drug that can cut HIV transmission from mothers to babies by up to 50%.
However, he proposed that “in the poorest areas” where such testing and counselling was not possible, pregnant women would immediately be offered Nevirapine “as a prophylactic measure”.
“Intervention should be based upon the universal administration of Nevirapine to pregnant women during childbirth, and to their children, save only where there is a decision by the women in question to decline the administration of Nevirapine,” said Mtshali.
He added that he had been advised that the universal prophylactic use of Nevirapine was in line with other practices “to deal with the possible infection of persons with suspected prevalent infectious disease”, such as anti-tetanus injections and polio vaccines.
HIV/AIDS expert Professor Jerry Coovadia said while he understood and supported Mtshali’s wish to provide universal access to Nevirapine, most African AIDS experts felt it was essential that people had, “as a minimum”, access to HIV counselling, if not to HIV tests.
“Counselling reduces the spread of HIV by encouraging behaviour change. It also encourages people to deal with their HIV status rather than driving it underground,” said Coovadia, who added that South Africa had the capacity to quickly train lay counsellors to meet the need.
Meanwhile, the Treatment Action Campaign welcomed Mtshali’s announcement and has planned a victory march to the Premier’s office leaving from the Durban City Hall at noon tomorrow (sat).
TAC, which initiated the case to force government to roll out Nevirapine, said it would be monitoring KwaZulu-Natal’s roll-out of Nevirapine. The organisation is also launching a campaign for prophylactic anti-retroviral treatment for all rape survivors and for a pilot study on anti-retroviral drugs for people with HIV.
Author
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
KZN join TAC in MTCT court case against Government
by Health-e News, Health-e News
March 1, 2002